Wellcome Trust’s Mastercard MA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$369M Buy
717,500
+47,500
+7% +$23.7M 4.09% 13
2026
Q1
$335M Buy
670,000
+75,000
+13% +$39.5M 4.14% 13
2025
Q4
$340M Hold
595,000
3.65% 14
2025
Q3
$338M Hold
595,000
3.68% 14
2025
Q2
$334M Buy
595,000
+40,000
+7% +$22.1M 3.86% 12
2025
Q1
$304M Hold
555,000
3.8% 13
2024
Q4
$292M Hold
555,000
3.53% 17
2024
Q3
$274M Hold
555,000
3.34% 17
2024
Q2
$245M Hold
555,000
3.13% 17
2024
Q1
$267M Hold
555,000
3.21% 18
2023
Q4
$237M Hold
555,000
2.93% 19
2023
Q3
$220M Hold
555,000
2.92% 20
2023
Q2
$218M Hold
555,000
2.87% 19
2023
Q1
$202M Hold
555,000
2.81% 20
2022
Q4
$193M Hold
555,000
2.85% 20
2022
Q3
$158M Buy
555,000
+155,000
+39% +$51.4M 2.47% 21
2022
Q2
$126M Hold
400,000
1.65% 23
2022
Q1
$143M Buy
400,000
+207,000
+107% +$74.4M 1.49% 23
2021
Q4
$69.3M Buy
+193,000
New +$66.7M 0.66% 24

Other funds holding MA

Wellcome Trust's MA Position: Q2 2026 in Review

Wellcome Trust increased its Mastercard (MA) stake by 7.1% in Q2 2026, buying an estimated $23.7M and bringing the position to 717,500 shares worth $369M. The position accounts for 4.09% of the portfolio, ranked #13.

Wellcome Trust first reported a position in MA in Q4 2021 and has held it in 19 quarters since. 614 funds tracked by Wall St. Rank hold MA as of Q2 2026.

  • Wellcome Trust held 717,500 shares of Mastercard worth $369M as of Q2 2026.
  • Wellcome Trust bought 47,500 Mastercard shares in Q2 2026, an estimated $23.7M.
  • Mastercard made up 4.09% of Wellcome Trust's portfolio in Q2 2026, its #13 holding.
  • Wellcome Trust first reported a position in Mastercard in Q4 2021 and has held it in 19 quarters since.
  • 614 funds tracked by Wall St. Rank held Mastercard as of Q2 2026.

Based on Wellcome Trust's 13F filing for Q2 2026, filed 9 Jul 2026.